Skip to main content
Enterprise AI Analysis: Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment

Enterprise AI Analysis: Healthcare AI

Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment

Published: 17 November 2025 by Leeann D. Louis, Edgar A. Wakelin, Matthew P. McCabe, Annie Y. Ng, Jiye G. Kim, Christoph I. Lee, Diana S. M. Buist, A. Gregory Sorensen, Bryan Haslam

This study demonstrates that a novel AI-driven workflow for breast cancer screening significantly enhances early cancer detection in a real-world US setting. The implementation of this multistage AI workflow led to a +21.6% increase in the Cancer Detection Rate (CDR), improving it from 4.6 to 5.6 per 1,000 exams. Crucially, these benefits were found to be equitable across all racial and breast density subpopulations, with CDR increases ranging from 20.4% to 22.7% and no observed disparities in outcomes. The workflow, integrating AI-based computer-aided detection and an AI-driven safeguard review by specialists for at-risk cases, also resulted in a +15.0% increase in positive predictive value (PPV1), signifying more appropriate recalls. This large-scale deployment across four US states validates AI's potential to improve screening effectiveness and equity in diverse healthcare environments.

Executive Impact

A novel AI workflow in breast cancer screening delivers substantial improvements in cancer detection rates with proven equitable benefits across diverse patient populations in real-world US deployment.

0 Increase in Cancer Detection Rate (CDR)
0 Increase in Positive Predictive Value (PPV1)
0 Exams Processed by AI Workflow

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

+21.6% Increase in Cancer Detection Rate (CDR)

The AI-driven workflow significantly improved early breast cancer detection across the US, detecting 21.6% more cancers compared to the standard of care (5.6 vs 4.6 per 1,000).

AI-Driven Breast Cancer Screening Workflow

Images Acquired
Initial AI Interpretation (CADe/x)
AI-driven Safeguard Review (for at-risk cases)
Breast Imaging Specialist Review (if needed)
Final Interpretation Report

The workflow integrates AI-based computer-aided detection (CADe/x) for initial interpretation and an AI-driven safeguard review by a breast imaging specialist for cases identified as at-risk but not recalled initially.

Category AI Workflow Benefits
Racial & Ethnic Subpopulations
  • No CDR, RR, or PPV₁ disparities found with AI workflow.
  • CDR increases between 20.4% and 22.7% across Black, Hispanic, and White non-Hispanic women.
Breast Density Subpopulations
  • No CDR, RR, or PPV₁ disparities found with AI workflow.
  • Increased CDR in both dense (+22.7%) and non-dense breasts (+21.0%).

A crucial finding highlights the equitable impact of the AI workflow, showing consistent improvements and no new disparities in outcomes across different racial/ethnic groups and breast densities, addressing a significant need in US healthcare.

Real-World US-Wide Deployment

Successful Implementation Across Diverse Outpatient Settings

The ASSURE study represents a large-scale, real-world deployment of the multistage AI-driven workflow across 5 practices (109 sites, 96 radiologists) in California, Delaware, Maryland, and New York. This demonstrates the scalability and practical effectiveness of AI in routine clinical use, handling 208,891 AI-driven exams.

  • Study included 579,583 exams in total, with 208,891 processed by the AI workflow.
  • Addressed the unique US screening paradigm: digital breast tomosynthesis (DBT), single-reading, annual cadence.
  • Zero adverse events were reported during the study period, indicating safe deployment.

Advanced ROI Calculator

Understand the potential return on investment for integrating AI into your enterprise. Adjust the parameters to see estimated efficiency gains and cost savings tailored to your organization.

Estimated Annual Savings $0
Annual Hours Reclaimed 0

Your AI Implementation Roadmap

Our proven methodology ensures a smooth and effective integration of AI into your enterprise. Each phase is designed to maximize your ROI and minimize disruption.

Phase 1: Discovery & Strategy

Assess current workflows, identify key integration points, and define custom AI strategies aligned with your business objectives. Our experts conduct a thorough analysis.

Phase 2: Pilot & Optimization

Deploy AI in a controlled pilot environment, gather initial performance data, and fine-tune algorithms for optimal results. Focus on specific departmental needs and user feedback.

Phase 3: Full-Scale Deployment

Roll out the AI workflow across your enterprise, providing comprehensive training and ongoing support. Monitor performance and ensure seamless operation and sustained benefits.

Phase 4: Continuous Improvement

Regularly review AI performance, identify new opportunities for enhancement, and scale the solution to additional areas. Stay ahead with iterative updates and advanced features.

Ready to Transform Your Enterprise with AI?

Schedule a personalized strategy session with our AI specialists. Discover how an equitable and impactful AI workflow can drive efficiency, enhance detection, and deliver measurable results for your organization.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking